Robert Haile to Neoplasms
This is a "connection" page, showing publications Robert Haile has written about Neoplasms.
Connection Strength
1.063
-
"Cancer Center Catchment Area Assessment"-Letter. Cancer Epidemiol Biomarkers Prev. 2022 07 01; 31(7):1507.
Score: 0.364
-
A review of cancer in U.S. Hispanic populations. Cancer Prev Res (Phila). 2012 Feb; 5(2):150-63.
Score: 0.177
-
Cancer Risks for PMS2-Associated Lynch Syndrome. J Clin Oncol. 2018 10 10; 36(29):2961-2968.
Score: 0.070
-
Trends in Cancer Survival by Health Insurance Status in California From 1997 to 2014. JAMA Oncol. 2018 Mar 01; 4(3):317-323.
Score: 0.067
-
Racial and Ethnic Disparities in Cancer Survival: The Contribution of Tumor, Sociodemographic, Institutional, and Neighborhood Characteristics. J Clin Oncol. 2018 01 01; 36(1):25-33.
Score: 0.066
-
The Patient Protection and Affordable Care Act dependent coverage expansion: Disparities in impact among young adult oncology patients. Cancer. 2018 Jan 01; 124(1):110-117.
Score: 0.065
-
Adolescent and young adult oncology patients: Disparities in access to specialized cancer centers. Cancer. 2017 Jul 01; 123(13):2516-2523.
Score: 0.063
-
Risk of extracolonic cancers for people with biallelic and monoallelic mutations in MUTYH. Int J Cancer. 2016 10 01; 139(7):1557-63.
Score: 0.060
-
Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: a prospective cohort study. J Clin Oncol. 2012 Mar 20; 30(9):958-64.
Score: 0.044
-
Cancer risks for monoallelic MUTYH mutation carriers with a family history of colorectal cancer. Int J Cancer. 2011 Nov 01; 129(9):2256-62.
Score: 0.042
-
Risks of colorectal and other cancers after endometrial cancer for women with Lynch syndrome. J Natl Cancer Inst. 2013 Feb 20; 105(4):274-9.
Score: 0.012
-
Reproductive factors and risk of contralateral breast cancer by BRCA1 and BRCA2 mutation status: results from the WECARE study. Cancer Causes Control. 2010 Jun; 21(6):839-46.
Score: 0.010
-
Risks of Lynch syndrome cancers for MSH6 mutation carriers. J Natl Cancer Inst. 2010 Feb 03; 102(3):193-201.
Score: 0.010
-
Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA. 2007 Jun 06; 297(21):2351-9.
Score: 0.008
-
Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X. JAMA. 2005 Apr 27; 293(16):1979-85.
Score: 0.007